The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Mylan Inc

Nasdaq: MYL
Last

(U.S.) $58.62

Today's change+2.45 +4.36%
Updated November 26 4:00 PM EST. Delayed by at least 15 minutes.
 

Mylan Inc

Nasdaq: MYL
Last

(U.S.) $58.62

Today's change+2.45 +4.36%
Updated November 26 4:00 PM EST. Delayed by at least 15 minutes.

Mylan Inc Hits New 52-week High

Mylan Inc closed up sharply Wednesday, rallying (U.S.)$2.45 or 4.36% to (U.S.)$58.62 and setting a new 52-week high. Over the last five days, shares have gained 5.28% and 35.07% year to date. Shares have outperformed the S&P 500 by 17.03% during the last year.

Key company metrics

  • Open(U.S.) $56.87
  • Previous close(U.S.) $56.17
  • High(U.S.) $59.12
  • Low(U.S.) $56.73
  • Bid / Ask-- / --
  • YTD % change+35.07%
  • Volume6,204,986
  • Average volume (10-day)3,645,055
  • Average volume (1-month)3,543,877
  • Average volume (3-month)4,333,011
  • 52-week range(U.S.) $41.26 to (U.S.) $59.12
  • Beta1.22
  • Trailing P/E25.29×
  • P/E 1 year forward16.49×
  • Forward PEG1.17×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.32
Updated November 26 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+12.40%

Based on its net profit margin of 12.40%, Mylan Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.77%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue2,0841,8371,7161,809
Total other revenue--------
Total revenue2,0841,8371,7161,809
Gross profit1,024819748818
Total cost of revenue1,0601,019968990
Total operating expense1,5931,6121,4801,531
Selling / general / administrative379356335340
Research & development157139117130
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)77976071
Other operating expenses, total-80------
Operating income491226236278
Interest income (expense), net non-operating-92-93-91-84
Gain (loss) on sale of assets--------
Other--------
Income before tax413138152193
Income after tax499127117181
Income tax, total-87113512
Net income499125116180
Total adjustments to net income------0
Net income before extra. items499125116180
Minority interest0-1-1-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items499125116180
Inc. avail. to common incl. extra. items499125116180
Diluted net income499125116180
Dilution adjustment------0
Diluted weighted average shares397397397396
Diluted EPS excluding extraordinary itemsvalue per share1.260.320.290.45
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.380.540.400.62